CAI
Price
$34.85
Change
-$1.50 (-4.13%)
Updated
Sep 5 closing price
Capitalization
9.8B
88 days until earnings call
VTGN
Price
$3.55
Change
-$0.07 (-1.93%)
Updated
Sep 5 closing price
Capitalization
108.92M
Interact to see
Advertisement

CAI vs VTGN

Header iconCAI vs VTGN Comparison
Open Charts CAI vs VTGNBanner chart's image
Caris Life Sciences
Price$34.85
Change-$1.50 (-4.13%)
Volume$541.87K
Capitalization9.8B
VistaGen Therapeutics
Price$3.55
Change-$0.07 (-1.93%)
Volume$273.89K
Capitalization108.92M
CAI vs VTGN Comparison Chart in %
Loading...
CAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAI vs. VTGN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CAI: $34.85 vs. VTGN: $3.55)
Brand notoriety: CAI and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 88% vs. VTGN: 55%
Market capitalization -- CAI: $9.8B vs. VTGN: $108.92M
CAI [@Biotechnology] is valued at $9.8B. VTGN’s [@Biotechnology] market capitalization is $108.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • CAI’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than CAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • CAI’s TA Score: 4 bullish, 5 bearish.
  • VTGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than CAI.

Price Growth

CAI (@Biotechnology) experienced а -9.22% price change this week, while VTGN (@Biotechnology) price change was +6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CAI is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($9.8B) has a higher market cap than VTGN($109M). VTGN YTD gains are higher at: 20.339 vs. CAI (-37.768). VTGN has higher annual earnings (EBITDA): -58.99M vs. CAI (-186.94M). CAI has more cash in the bank: 721M vs. VTGN (63.2M). VTGN has less debt than CAI: VTGN (2.36M) vs CAI (419M). CAI has higher revenues than VTGN: CAI (534M) vs VTGN (646K).
CAIVTGNCAI / VTGN
Capitalization9.8B109M8,993%
EBITDA-186.94M-58.99M317%
Gain YTD-37.76820.339-186%
P/E RatioN/AN/A-
Revenue534M646K82,663%
Total Cash721M63.2M1,141%
Total Debt419M2.36M17,784%
FUNDAMENTALS RATINGS
CAI vs VTGN: Fundamental Ratings
CAI
VTGN
OUTLOOK RATING
1..100
755
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6439
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAI's Valuation (2) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for VTGN (50) in the Biotechnology industry. This means that CAI’s stock grew somewhat faster than VTGN’s over the last 12 months.

CAI's Profit vs Risk Rating (69) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (100) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that VTGN’s stock grew similarly to CAI’s over the last 12 months.

VTGN's Price Growth Rating (39) in the Biotechnology industry is in the same range as CAI (64) in the Finance Or Rental Or Leasing industry. This means that VTGN’s stock grew similarly to CAI’s over the last 12 months.

VTGN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that VTGN’s stock grew similarly to CAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAIVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
10%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
68%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
31%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KASHF0.02N/A
+18.93%
INTELLABRIDGE TECHNOLOGY CORP.
SOMLY9.330.05
+0.54%
Secom Co., Ltd.
CMTOY12.74N/A
N/A
Cementos Argos S.A.
NWBO0.25-0.01
-2.84%
Northwest Biotherapeutics, Inc.
LIMX2.05-0.44
-17.67%
Limitless X Holdings Inc.

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-4.13%
BMEA - CAI
38%
Loosely correlated
+4.92%
VTGN - CAI
26%
Poorly correlated
-1.93%
CERO - CAI
22%
Poorly correlated
-14.57%
CRDF - CAI
21%
Poorly correlated
+1.88%
LIXT - CAI
20%
Poorly correlated
+2.24%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-1.93%
COGT - VTGN
41%
Loosely correlated
+0.85%
IMNM - VTGN
39%
Loosely correlated
+7.35%
IPSC - VTGN
39%
Loosely correlated
+5.41%
CRIS - VTGN
38%
Loosely correlated
-1.75%
SRRK - VTGN
38%
Loosely correlated
-3.18%
More